newsfilter
← Latest News
GlobeNewswire·

ARCA biopharma Announces Second Quarter 2024 Financial Results and Provides Corporate Update

WESTMINSTER, Colo., Aug. 01, 2024 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (NASDAQ:ABIO), (the "Company") a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies